Company Information

Innovacell GmbH

  1. Home
  2. Company Information
  3. Corporate Profile
  4. Innovacell GmbH

Corporate Profile

Company Name Innovacell GmbH
Head office Mitterweg 24, 6020 Innsbruck, Austria
Contact Tel: +43 (0)512 573680
Email Address: office@innovacell.com
What we do
  • Innovacell is a biotechnology company focused on developing, producing and marketing cell therapies for treating fecal and urinary incontinence. Technologies for isolating, multiplying, using and delivering muscle cells have been developed. Associated patents have already been granted or their applications filed.
  • Innovacell works according to the rules of “Good Laboratory Practice” (GLP), “Good Manufacturing Practice” (GMP) and “Good Clinical Practice” (GCP). These guidelines ensure that internationally recognized quality standards are met while developing, manufacturing, processing, packaging and storing pharmaceuticals and that customers and patients receive products of the highest quality.
  • Innovacell is one of the largest producers of autologous (endogenous) in vitro multiplied cells in Europe.
  • Innovacell has approval to manufacture cell therapy test material for clinical studies. This includes currently the following cell types: autologous skeletal muscle cells, skin fibroblasts, and hair follicle cells.
  • Innovacell aims to market the products it has developed in the five key European countries (Germany, France, Italy, Spain and the United Kingdom) as well as in Japan and the USA. The goal is to become a global leader in the field of regenerative medicine with a focus on innovative, personalized cell therapies.
Commercial Register Number / Competent Court FN 545280h / Landesgericht Innsbruck
Supervisory Authority BASG (Bundesamt für Sicherheit im Gesundheitswesen)
Chamber Membership Wirtschaftskammer Tirol (Membership No. 473499)
Applicable Professional or Trade Regulations Gewerbeordnung (GewO)
VAT Identification Number (UID) ATU76336706
Business Activities Development, manufacturing, and sale of cell therapies for the treatment of fecal and urinary incontinence
Authorized Representatives
  • Dr. Rainer Marksteiner
  • Colin Lee Novick
  • Jason David Sieger
  • Yasushi Hosono
Shareholder Innovacell Inc. (100%), located and registered in Japan
Editorial Policy This website provides information about the company and its activities in the field of cell therapy.
PAGE TOP